Health
Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine – News-Medical.Net
Cellid and the International Vaccine Institute have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19″….
Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.
Cellid and IVI announced on January 4 that they have signed a research service contract to cooperate in the clinical development of the “AdCLD-CoV19”, a COVID-19 vaccine being developed by Cellid.
Under this contract, IVI will analyze samples from Phase 1/2a clinical trials of Cellid’s COVID-19 vaccine “AdCLD-CoV19” to determine…
-
Noosa News18 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General18 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News19 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
Noosa News22 hours agoFlawed government agreement opened door for unlawful site access